drugset / Trial / NCT05794581
A Study to Assess the Effects of CT-868 Treatment on Glucose Homeostasis in Participants with Type 1 Diabetes
RandomizedCrossoverQuadruple-blindTreatment
Summary
This study will be conducted primarily to evaluate the effects of CT-868 on glucose homeostasis in participants with Type 1 Diabetes Mellitus.
Timeline
- Start
- 2023-03-21
- Primary completion
- 2024-03-06
- Completion
- 2024-04-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | CT-868 | Unknown | — | Subcutaneous |
| Comparator | Liraglutide | Peptide | — | Subcutaneous |